Literature DB >> 28645013

Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.

Rachel Rogers Worley1, Susan McAfee Moore2, Bruce C Tierney2, Xiaoyun Ye3, Antonia M Calafat3, Sean Campbell4, Million B Woudneh4, Jeffrey Fisher5.   

Abstract

BACKGROUND: Per- and polyfluoroalkyl substances (PFAS) are considered chemicals of emerging concern, in part due to their environmental and biological persistence and the potential for widespread human exposure. In 2007, a PFAS manufacturer near Decatur, Alabama notified the United States Environmental Protection Agency (EPA) it had discharged PFAS into a wastewater treatment plant, resulting in environmental contamination and potential exposures to the local community.
OBJECTIVES: To characterize PFAS exposure over time, the Agency for Toxic Substances and Disease Registry (ATSDR) collected blood and urine samples from local residents.
METHODS: Eight PFAS were measured in serum in 2010 (n=153). Eleven PFAS were measured in serum, and five PFAS were measured in urine (n=45) from some of the same residents in 2016. Serum concentrations were compared to nationally representative data and change in serum concentration over time was evaluated. Biological half-lives were estimated for perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorohexane sulfonic acid (PFHxS) using a one-compartment pharmacokinetic model.
RESULTS: In 2010 and 2016, geometric mean PFOA and PFOS serum concentrations were elevated in participants compared to the general U.S. POPULATION: In 2016, the geometric mean PFHxS serum concentration was elevated compared to the general U.S. POPULATION: Geometric mean serum concentrations of PFOA, PFOS, and perfluorononanoic acid (PFNA) were significantly (p≤0.0001) lower (49%, 53%, and 58%, respectively) in 2016 compared to 2010. Half-lives for PFOA, PFOS, and PFHxS were estimated to be 3.9, 3.3, and 15.5years, respectively. Concentrations of PFOA in serum and urine were highly correlated (r=0.75) in males.
CONCLUSIONS: Serum concentrations of some PFAS are decreasing in this residentially exposed community, but remain elevated compared to the U.S. general population. Published by Elsevier Ltd.

Entities:  

Keywords:  Biomonitoring; Half-life; PFAS; PFOA; PFOS

Mesh:

Substances:

Year:  2017        PMID: 28645013      PMCID: PMC5673082          DOI: 10.1016/j.envint.2017.06.007

Source DB:  PubMed          Journal:  Environ Int        ISSN: 0160-4120            Impact factor:   9.621


  64 in total

1.  Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction.

Authors:  Zsuzsanna Kuklenyik; Larry L Needham; Antonia M Calafat
Journal:  Anal Chem       Date:  2005-09-15       Impact factor: 6.986

2.  Effects of perfluorooctanoic acid exposure during pregnancy in the mouse.

Authors:  Christopher Lau; Julie R Thibodeaux; Roger G Hanson; Michael G Narotsky; John M Rogers; Andrew B Lindstrom; Mark J Strynar
Journal:  Toxicol Sci       Date:  2006-01-16       Impact factor: 4.849

3.  Quantitative characterization of trace levels of PFOS and PFOA in the Tennessee River.

Authors:  K J Hansen; H O Johnson; J S Eldridge; J L Butenhoff; L A Dick
Journal:  Environ Sci Technol       Date:  2002-04-15       Impact factor: 9.028

4.  Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations.

Authors:  Geary W Olsen; Jean M Burris; Michele M Burlew; Jeffrey H Mandel
Journal:  J Occup Environ Med       Date:  2003-03       Impact factor: 2.162

5.  PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men.

Authors:  Ulla Nordström Joensen; Bruno Veyrand; Jean-Philippe Antignac; Martin Blomberg Jensen; Jørgen Holm Petersen; Philippe Marchand; Niels Erik Skakkebæk; Anna-Maria Andersson; Bruno Le Bizec; Niels Jørgensen
Journal:  Hum Reprod       Date:  2012-12-18       Impact factor: 6.918

6.  Thirty years of medical surveillance in perfluooctanoic acid production workers.

Authors:  Giovanni Costa; Samantha Sartori; Dario Consonni
Journal:  J Occup Environ Med       Date:  2009-03       Impact factor: 2.162

7.  Case-control study on perfluorinated alkyl acids (PFAAs) and the risk of prostate cancer.

Authors:  Elin Hardell; Anna Kärrman; Bert van Bavel; Jia Bao; Michael Carlberg; Lennart Hardell
Journal:  Environ Int       Date:  2013-11-16       Impact factor: 9.621

8.  Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant.

Authors:  Vaughn Barry; Andrea Winquist; Kyle Steenland
Journal:  Environ Health Perspect       Date:  2013-09-05       Impact factor: 9.031

9.  Breast cancer risk after exposure to perfluorinated compounds in Danish women: a case-control study nested in the Danish National Birth Cohort.

Authors:  Eva C Bonefeld-Jørgensen; Manhai Long; Stine Overvad Fredslund; Rossana Bossi; Jørn Olsen
Journal:  Cancer Causes Control       Date:  2014-08-23       Impact factor: 2.506

10.  The C8 health project: design, methods, and participants.

Authors:  Stephanie J Frisbee; A Paul Brooks; Arthur Maher; Patsy Flensborg; Susan Arnold; Tony Fletcher; Kyle Steenland; Anoop Shankar; Sarah S Knox; Cecil Pollard; Joel A Halverson; Verónica M Vieira; Chuanfang Jin; Kevin M Leyden; Alan M Ducatman
Journal:  Environ Health Perspect       Date:  2009-07-13       Impact factor: 9.031

View more
  35 in total

1.  Perfluoroalkyl acids, hyperuricemia and gout in adults: Analyses of NHANES 2009-2014.

Authors:  Franco Scinicariello; Melanie C Buser; Lina Balluz; Kimberly Gehle; H Edward Murray; Henry G Abadin; Roberta Attanasio
Journal:  Chemosphere       Date:  2020-06-20       Impact factor: 7.086

2.  Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood.

Authors:  Samantha L Kingsley; Melissa N Eliot; Karl T Kelsey; Antonia M Calafat; Shelley Ehrlich; Bruce P Lanphear; Aimin Chen; Joseph M Braun
Journal:  Environ Res       Date:  2018-05-07       Impact factor: 6.498

3.  Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.

Authors:  Ning Ding; Siobán D Harlow; John F Randolph; Rita Loch-Caruso; Sung Kyun Park
Journal:  Hum Reprod Update       Date:  2020-09-01       Impact factor: 15.610

4.  Examining Endocrine Disruptors Measured in Newborn Dried Blood Spots and Early Childhood Growth in a Prospective Cohort.

Authors:  Edwina H Yeung; Erin M Bell; Rajeshwari Sundaram; Akhgar Ghassabian; Wanli Ma; Kurunthachalam Kannan; Germaine M Louis
Journal:  Obesity (Silver Spring)       Date:  2019-01       Impact factor: 5.002

5.  Temporal trends and determinants of serum concentrations of per- and polyfluoroalkyl substances among Northern California mothers with a young child, 2009-2016.

Authors:  Kyunghoon Kim; Deborah H Bennett; Antonia M Calafat; Irva Hertz-Picciotto; Hyeong-Moo Shin
Journal:  Environ Res       Date:  2020-04-09       Impact factor: 6.498

6.  Per- and polyfluoroalkyl substances impact human spermatogenesis in a stem-cell-derived model.

Authors:  Alyse N Steves; Adam Turry; Brittany Gill; Danielle Clarkson-Townsend; Joshua M Bradner; Ian Bachli; W Michael Caudle; Gary W Miller; Anthony W S Chan; Charles A Easley
Journal:  Syst Biol Reprod Med       Date:  2018-06-18       Impact factor: 3.061

7.  Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines.

Authors:  John Bassler; Alan Ducatman; Meenal Elliott; Sijin Wen; Banrida Wahlang; John Barnett; Matthew C Cave
Journal:  Environ Pollut       Date:  2019-01-18       Impact factor: 8.071

8.  Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.

Authors:  Rachel Rogers Worley; Xiaoxia Yang; Jeffrey Fisher
Journal:  Toxicol Appl Pharmacol       Date:  2017-07-03       Impact factor: 4.219

9.  Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: Paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey.

Authors:  Antonia M Calafat; Kayoko Kato; Kendra Hubbard; Tao Jia; Julianne Cook Botelho; Lee-Yang Wong
Journal:  Environ Int       Date:  2019-07-31       Impact factor: 9.621

Review 10.  Chemical Exposures, Health, and Environmental Justice in Communities Living on the Fenceline of Industry.

Authors:  Jill Johnston; Lara Cushing
Journal:  Curr Environ Health Rep       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.